Abstract
Gender bias in medicine is not a new issue, with treatment bias known to affect outcomes. In settings such as cardiovascular disease, such disparities have been shown to lead to under-representation or even exclusion of women from clinical research. The intersection of this bias along with the historically taboo topic of sexual and genital health has naturally led to delayed progress in female genital disease. As recently as 2017, the US Preventative Health Taskforce reported that primary gynaecological physical assessment lacks utility when performed in asymptomatic women, apart from the detection of cervical cancer or specific genital infections, highlighting the paucity of evidence in this area.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
